Terns Pharmaceuticals (TERN) Current Leases (2022 - 2023)
Terns Pharmaceuticals' Current Leases history spans 2 years, with the latest figure at $707000.0 for Q3 2023.
- For Q3 2023, Current Leases rose 6.32% year-over-year to $707000.0; the TTM value through Sep 2023 reached $707000.0, up 6.32%, while the annual FY2022 figure was $661000.0, N/A changed from the prior year.
- Current Leases reached $707000.0 in Q3 2023 per TERN's latest filing, up from $653000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $707000.0 in Q3 2023 to a low of $584000.0 in Q1 2022.